24 May 2013
Keywords: novartis, files, new, use, diovan, submitted, regulatory
Article | 09 February 2004
Novartis has submitted regulatory applications to a range of authorities for a new indication for its Diovan (valsartan) to improve ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 February 2004
© 2013 thepharmaletter.com